Anti cancer innovative drugs have been approved for domestic clinical trials! There is hope for a va

Mondo Health Updated on 2024-02-08

The anti-cancer innovative drug QBH-196 tablets in clinical trials in many countries have been successfully approved for domestic clinical trials, this good news has made many patients with poor cancer see the hope of saving lives, this clinical trial is mainly for liver cancer, lung cancer, pancreatic cancer, oral cancer, tongue cancer, stomach cancer, tongue cancer, ovarian cancer, uterine cancer and other cancer diseases!

The inhibitory activity of QBH-196 against FLT3, KIT, MEK5, RET and TRKA was better than that of cabozantinib, and the activity against VEGFR2 was significantly better than that of its specific inhibitor apatinib. It has a strong growth inhibitory effect on 12 different types of human tumor cell lines. There are many cancer patients in China, but many patients lack effective anti-cancer methods, and the clinical practice of new drugs is the key to saving the lives of many patients!

Shanghai East Hospital, Shandong Provincial Cancer Hospital, the First Affiliated Hospital of Nanchang University, Shenzhen Longhua District People's Hospital, etc. have all opened a window for patients. There are still some opportunities in the clinic, patients should not miss it!

The new drug is clinically available**Collection, I hope that patients who enter the clinic can follow me, thank you!

Related Pages